Willett, B., Grove, J., MacLean, O., Wilkie, C., De Lorenzo, G., Furnon, W., Cantoni, D., Scott, S., Logan, N., Ashraf, S., Manali, M., Szemiel, A., Cowton, V., Vink, E., Harvey, W., Davis, C., Asamaphan, P., Smollett, K., Tong, L., Orton, R., Hughes, J., Holland, P., Silva, V., Pascall, D., Puxty, K., da Silva Filipe, A., Yebra, G., Shaaban, S., Holden, M., Pinto, R., Gunson, R., Templeton, K., Murcia, P., Patel, A., Klenerman, P., Dunachie, S., PITCH Consortium, The COVID-19 Genomics UK (COG-UK) Consortium, Haughney, J., Robertson, D., Palmarini, M., Ray, S. & Thomson, E. 2022, 'SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway', Nature Microbiology. http://dx.doi.org/10.1038/s41564-022-01143-7